XML 41 R33.htm IDEA: XBRL DOCUMENT v3.19.2
Product Sales Analysis - Q2 2019 (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2017
Sep. 30, 2017
Jun. 30, 2017
Mar. 31, 2017
Jun. 30, 2019
Product sales                      
Product Sales $ 5,718 $ 5,465 $ 5,768 $ 5,266 $ 5,030 $ 4,985 $ 5,487 $ 4,882 $ 4,940 $ 4,843 $ 1,540
Actual %, year-on-year 14.00%                   16.00%
CER %, year-on-year 19.00%                   19.00%
Emerging Markets                      
Product sales                      
Product Sales $ 1,947                   $ 3,951
Actual %, year-on-year 17.00%                   15.00%
CER %, year-on-year 27.00%                   24.00%
US                      
Product sales                      
Product Sales $ 1,877                   $ 3,663
Actual %, year-on-year 16.00%                   18.00%
Europe                      
Product sales                      
Product Sales $ 1,047                   $ 2,029
Actual %, year-on-year 1.00%                   (6.00%)
CER %, year-on-year 8.00%                   (1.00%)
World                      
Product sales                      
Product Sales $ 847                   $ 11,183
Actual %, year-on-year 17.00%                   12.00%
CER %, year-on-year 21.00%                   17.00%
Oncology                      
Product sales                      
Product Sales $ 2,167 1,892 1,767 1,597 1,434 1,230 1,120 1,026 993 885 $ 740
Actual %, year-on-year 51.00%                   65.00%
CER %, year-on-year 57.00%                   69.00%
Oncology | Emerging Markets                      
Product sales                      
Product Sales $ 558                   $ 1,048
Actual %, year-on-year 45.00%                   40.00%
CER %, year-on-year 57.00%                   52.00%
Oncology | US                      
Product sales                      
Product Sales $ 851                   $ 1,621
Actual %, year-on-year 58.00%                   68.00%
Oncology | Europe                      
Product sales                      
Product Sales $ 336                   $ 650
Actual %, year-on-year 31.00%                   29.00%
CER %, year-on-year 41.00%                   37.00%
Oncology | World                      
Product sales                      
Product Sales $ 422                   $ 4,059
Actual %, year-on-year 65.00%                   52.00%
CER %, year-on-year 70.00%                   58.00%
Tagrisso                      
Product sales                      
Product Sales $ 784 630 594 506 422 338 304 248 232 171 $ 314
Actual %, year-on-year 86.00%                    
CER %, year-on-year 92.00%                    
Tagrisso | Emerging Markets                      
Product sales                      
Product Sales $ 191                   329
Tagrisso | US                      
Product sales                      
Product Sales $ 300                   $ 559
Actual %, year-on-year 55.00%                   64.00%
Tagrisso | Europe                      
Product sales                      
Product Sales $ 112                   $ 212
Actual %, year-on-year 60.00%                   53.00%
CER %, year-on-year 73.00%                   64.00%
Tagrisso | World                      
Product sales                      
Product Sales $ 181                   $ 1,414
Actual %, year-on-year                     86.00%
CER %, year-on-year                     92.00%
Imfinzi                      
Product sales                      
Product Sales 338 295 262 187 122 62 18   1   $ 88
Imfinzi | Emerging Markets                      
Product sales                      
Product Sales 6                   12
Imfinzi | US                      
Product sales                      
Product Sales 242                   473
Imfinzi | Europe                      
Product sales                      
Product Sales 37                   60
Imfinzi | World                      
Product sales                      
Product Sales 53                   633
Lynparza                      
Product sales                      
Product Sales $ 283 237 209 169 150 119 100 81 59 57 68
Actual %, year-on-year 89.00%                    
CER %, year-on-year 95.00%                    
Lynparza | Emerging Markets                      
Product sales                      
Product Sales $ 33                   59
Lynparza | US                      
Product sales                      
Product Sales $ 143                   $ 262
Actual %, year-on-year 72.00%                   76.00%
Lynparza | Europe                      
Product sales                      
Product Sales $ 66                   $ 131
Actual %, year-on-year 47.00%                   51.00%
CER %, year-on-year 60.00%                   61.00%
Lynparza | World                      
Product sales                      
Product Sales $ 41                   $ 520
Actual %, year-on-year                     93.00%
Iressa                      
Product sales                      
Product Sales $ 118 134 112 131 143 132 130 137 137 124 $ 34
Actual %, year-on-year (17.00%)                   (35.00%)
CER %, year-on-year (13.00%)                   (33.00%)
Iressa | Emerging Markets                      
Product sales                      
Product Sales $ 78                   $ 164
Actual %, year-on-year 1.00%                   11.00%
CER %, year-on-year 8.00%                   18.00%
Iressa | US                      
Product sales                      
Product Sales $ 4                   $ 8
Actual %, year-on-year (33.00%)                   (43.00%)
Iressa | Europe                      
Product sales                      
Product Sales $ 20                   $ 46
Actual %, year-on-year (35.00%)                   (25.00%)
CER %, year-on-year (32.00%)                   (20.00%)
Iressa | World                      
Product sales                      
Product Sales $ 16                   $ 252
Actual %, year-on-year (45.00%)                   (8.00%)
CER %, year-on-year (41.00%)                   (3.00%)
Calquence                      
Product sales                      
Product Sales $ 35 29 24 18 12 8 3        
Calquence | US                      
Product sales                      
Product Sales 35                   $ 64
Calquence | World                      
Product sales                      
Product Sales                     64
Faslodex                      
Product sales                      
Product Sales $ 267 254 269 258 247 254 238 241 248 214 $ 64
Actual %, year-on-year 8.00%                   21.00%
CER %, year-on-year 12.00%                   23.00%
Faslodex | Emerging Markets                      
Product sales                      
Product Sales $ 51                   $ 96
Actual %, year-on-year 59.00%                   35.00%
CER %, year-on-year 75.00%                   49.00%
Faslodex | US                      
Product sales                      
Product Sales $ 125                   $ 251
Actual %, year-on-year                     (3.00%)
Faslodex | Europe                      
Product sales                      
Product Sales $ 56                   $ 110
Actual %, year-on-year (5.00%)                   (7.00%)
CER %, year-on-year 2.00%                    
Faslodex | World                      
Product sales                      
Product Sales $ 35                   $ 521
Actual %, year-on-year 13.00%                   4.00%
CER %, year-on-year 16.00%                   8.00%
Zoladex                      
Product sales                      
Product Sales $ 197 194 182 194 192 184 187 185 178 185 $ 87
Actual %, year-on-year 3.00%                   (16.00%)
CER %, year-on-year 10.00%                   (13.00%)
Zoladex | Emerging Markets                      
Product sales                      
Product Sales $ 121                   $ 235
Actual %, year-on-year 20.00%                   16.00%
CER %, year-on-year 31.00%                   27.00%
Zoladex | US                      
Product sales                      
Product Sales $ 2                   $ 4
Actual %, year-on-year                     33.00%
Zoladex | Europe                      
Product sales                      
Product Sales $ 30                   $ 65
Actual %, year-on-year (12.00%)                   (4.00%)
CER %, year-on-year (6.00%)                   1.00%
Zoladex | World                      
Product sales                      
Product Sales $ 44                   $ 391
Actual %, year-on-year (20.00%)                   4.00%
CER %, year-on-year (16.00%)                   11.00%
Arimidex                      
Product sales                      
Product Sales $ 60 51 46 55 57 54 57 54 54 52 $ 24
Actual %, year-on-year 5.00%                   (4.00%)
CER %, year-on-year 14.00%                   (4.00%)
Arimidex | Emerging Markets                      
Product sales                      
Product Sales $ 36                   $ 72
Actual %, year-on-year                     1.00%
CER %, year-on-year 14.00%                   13.00%
Arimidex | Europe                      
Product sales                      
Product Sales $ 9                   $ 15
Actual %, year-on-year 29.00%                    
CER %, year-on-year 29.00%                    
Arimidex | World                      
Product sales                      
Product Sales $ 15                   $ 111
Actual %, year-on-year 7.00%                    
CER %, year-on-year 7.00%                   7.00%
Casodex                      
Product sales                      
Product Sales $ 57 48 46 51 52 52 54 51 54 56 $ 32
Actual %, year-on-year 10.00%                   (6.00%)
CER %, year-on-year 17.00%                   (3.00%)
Casodex | Emerging Markets                      
Product sales                      
Product Sales $ 34                   $ 65
Actual %, year-on-year 21.00%                   10.00%
CER %, year-on-year 32.00%                   19.00%
Casodex | Europe                      
Product sales                      
Product Sales $ 4                   $ 8
Actual %, year-on-year (20.00%)                   (27.00%)
CER %, year-on-year (20.00%)                   (27.00%)
Casodex | World                      
Product sales                      
Product Sales $ 19                   $ 105
Actual %, year-on-year                     1.00%
CER %, year-on-year 5.00%                   7.00%
Oncology, Others                      
Product sales                      
Product Sales $ 28 20 23 28 37 27 29 29 30 26 $ 29
Actual %, year-on-year (24.00%)                   (36.00%)
CER %, year-on-year (24.00%)                   (36.00%)
Oncology, Others | Emerging Markets                      
Product sales                      
Product Sales $ 8                   $ 16
Actual %, year-on-year (11.00%)                    
CER %, year-on-year (11.00%)                   6.00%
Oncology, Others | Europe                      
Product sales                      
Product Sales $ 2                   $ 3
Oncology, Others | World                      
Product sales                      
Product Sales $ 18                   $ 48
Actual %, year-on-year (31.00%)                   (25.00%)
CER %, year-on-year (31.00%)                   (23.00%)
BioPharmaceuticals, CVRM                      
Product sales                      
Product Sales $ 1,658 1,714 1,747 1,695 1,623 1,645 1,939 1,773 1,775 1,779 $ 273
Actual %, year-on-year 2.00%                    
CER %, year-on-year 7.00%                   3.00%
BioPharmaceuticals, CVRM | Emerging Markets                      
Product sales                      
Product Sales $ 701                   $ 1,448
Actual %, year-on-year 10.00%                   9.00%
CER %, year-on-year 19.00%                   18.00%
BioPharmaceuticals, CVRM | US                      
Product sales                      
Product Sales $ 527                   $ 1,085
Actual %, year-on-year (1.00%)                   5.00%
BioPharmaceuticals, CVRM | Europe                      
Product sales                      
Product Sales $ 283                   $ 566
Actual %, year-on-year (8.00%)                   (10.00%)
CER %, year-on-year (1.00%)                   (5.00%)
BioPharmaceuticals, CVRM | World                      
Product sales                      
Product Sales $ 147                   $ 3,372
Actual %, year-on-year (1.00%)                   3.00%
CER %, year-on-year 2.00%                   8.00%
Farxiga                      
Product sales                      
Product Sales $ 377 349 397 355 340 299 332 285 250 207 $ 72
Actual %, year-on-year 11.00%                   13.00%
CER %, year-on-year 16.00%                   16.00%
Farxiga | Emerging Markets                      
Product sales                      
Product Sales $ 111                   $ 206
Actual %, year-on-year 26.00%                   31.00%
CER %, year-on-year 40.00%                   45.00%
Farxiga | US                      
Product sales                      
Product Sales $ 139                   $ 270
Actual %, year-on-year                     2.00%
Farxiga | Europe                      
Product sales                      
Product Sales $ 89                   $ 178
Actual %, year-on-year 14.00%                   17.00%
CER %, year-on-year 22.00%                   26.00%
Farxiga | World                      
Product sales                      
Product Sales $ 38                   $ 726
Actual %, year-on-year 9.00%                   14.00%
CER %, year-on-year 9.00%                   19.00%
Brilinta                      
Product sales                      
Product Sales $ 389 348 376 336 316 293 299 284 272 224 $ 28
Actual %, year-on-year 23.00%                   (7.00%)
CER %, year-on-year 28.00%                    
Brilinta | Emerging Markets                      
Product sales                      
Product Sales $ 120                   $ 217
Actual %, year-on-year 67.00%                   47.00%
CER %, year-on-year 79.00%                   58.00%
Brilinta | US                      
Product sales                      
Product Sales $ 168                   $ 321
Actual %, year-on-year 17.00%                   24.00%
Brilinta | Europe                      
Product sales                      
Product Sales $ 88                   $ 171
Actual %, year-on-year 2.00%                   (1.00%)
CER %, year-on-year 10.00%                   7.00%
Brilinta | World                      
Product sales                      
Product Sales $ 13                   $ 737
Actual %, year-on-year (7.00%)                   21.00%
CER %, year-on-year                     26.00%
Onglyza                      
Product sales                      
Product Sales $ 116 153 148 140 126 129 180 127 150 154 $ 26
Actual %, year-on-year (8.00%)                   (10.00%)
CER %, year-on-year (4.00%)                   (7.00%)
Onglyza | Emerging Markets                      
Product sales                      
Product Sales $ 44                   $ 87
Actual %, year-on-year 7.00%                   7.00%
CER %, year-on-year 10.00%                   16.00%
Onglyza | US                      
Product sales                      
Product Sales $ 42                   $ 120
Actual %, year-on-year (14.00%)                   22.00%
Onglyza | Europe                      
Product sales                      
Product Sales $ 17                   $ 36
Actual %, year-on-year (29.00%)                   (23.00%)
CER %, year-on-year (17.00%)                   (17.00%)
Onglyza | World                      
Product sales                      
Product Sales $ 13                   $ 269
Actual %, year-on-year 8.00%                   5.00%
CER %, year-on-year 17.00%                   10.00%
Bydureon                      
Product sales                      
Product Sales $ 141 142 138 152 155 139 147 128 146 153 $ 8
Actual %, year-on-year (9.00%)                   (20.00%)
CER %, year-on-year (8.00%)                   (20.00%)
Bydureon | Emerging Markets                      
Product sales                      
Product Sales $ 5                   $ 7
Actual %, year-on-year (29.00%)                    
CER %, year-on-year (14.00%)                   29.00%
Bydureon | US                      
Product sales                      
Product Sales $ 117                   $ 234
Actual %, year-on-year (5.00%)                    
Bydureon | Europe                      
Product sales                      
Product Sales $ 16                   $ 34
Actual %, year-on-year (20.00%)                   (21.00%)
CER %, year-on-year (20.00%)                   (19.00%)
Bydureon | World                      
Product sales                      
Product Sales $ 3                   $ 283
Actual %, year-on-year (40.00%)                   (4.00%)
CER %, year-on-year (40.00%)                   (3.00%)
Byetta                      
Product sales                      
Product Sales $ 25 30 32 34 29 31 48 39 43 46 $ 6
Actual %, year-on-year (14.00%)                   (25.00%)
CER %, year-on-year (10.00%)                   (25.00%)
Byetta | Emerging Markets                      
Product sales                      
Product Sales $ 3                   $ 4
CER %, year-on-year                     50.00%
Byetta | US                      
Product sales                      
Product Sales $ 15                   $ 35
Actual %, year-on-year (12.00%)                   9.00%
Byetta | Europe                      
Product sales                      
Product Sales $ 4                   $ 10
Actual %, year-on-year (56.00%)                   (38.00%)
CER %, year-on-year (56.00%)                   (38.00%)
Byetta | World                      
Product sales                      
Product Sales $ 3                   $ 55
Actual %, year-on-year (25.00%)                   (8.00%)
CER %, year-on-year (25.00%)                   (5.00%)
Symlin                      
Product sales                      
Product Sales $ 8 7 10 8 7 9 13 10 11 14  
Actual %, year-on-year 14.00%                    
CER %, year-on-year 14.00%                    
Symlin | US                      
Product sales                      
Product Sales $ 8                   $ 15
Actual %, year-on-year 14.00%                   (6.00%)
Symlin | World                      
Product sales                      
Product Sales                     $ 15
Actual %, year-on-year                     (6.00%)
CER %, year-on-year                     (6.00%)
Crestor                      
Product sales                      
Product Sales $ 310 335 353 353 338 389 594 580 560 631 $ 109
Actual %, year-on-year (8.00%)                   7.00%
CER %, year-on-year (3.00%)                   11.00%
Crestor | Emerging Markets                      
Product sales                      
Product Sales $ 182                   $ 407
Actual %, year-on-year (2.00%)                   (4.00%)
CER %, year-on-year 4.00%                   2.00%
Crestor | US                      
Product sales                      
Product Sales $ 28                   $ 54
Actual %, year-on-year (36.00%)                   (40.00%)
Crestor | Europe                      
Product sales                      
Product Sales $ 36                   $ 75
Actual %, year-on-year (22.00%)                   (32.00%)
CER %, year-on-year (13.00%)                   (27.00%)
Crestor | World                      
Product sales                      
Product Sales $ 64                   $ 645
Actual %, year-on-year 3.00%                   (11.00%)
CER %, year-on-year 8.00%                   (6.00%)
Seloken/Toprol-XL                      
Product sales                      
Product Sales $ 168 225 160 179 173 200 168 160 181 186 $ 5
Actual %, year-on-year (3.00%)                   (29.00%)
CER %, year-on-year 5.00%                   (29.00%)
Seloken/Toprol-XL | Emerging Markets                      
Product sales                      
Product Sales $ 156                   $ 349
Actual %, year-on-year 1.00%                   6.00%
CER %, year-on-year 10.00%                   16.00%
Seloken/Toprol-XL | US                      
Product sales                      
Product Sales $ 3                   $ 26
Actual %, year-on-year (63.00%)                    
Seloken/Toprol-XL | Europe                      
Product sales                      
Product Sales $ 7                   $ 13
Actual %, year-on-year 17.00%                   8.00%
CER %, year-on-year 17.00%                   8.00%
Seloken/Toprol-XL | World                      
Product sales                      
Product Sales $ 2                   $ 393
Actual %, year-on-year (50.00%)                   5.00%
CER %, year-on-year (50.00%)                   14.00%
Atacand                      
Product sales                      
Product Sales $ 56 50 58 65 66 71 73 80 72 75 $ 9
Actual %, year-on-year (14.00%)                   (10.00%)
CER %, year-on-year (9.00%)                   (10.00%)
Atacand | Emerging Markets                      
Product sales                      
Product Sales $ 37                   $ 76
Actual %, year-on-year (3.00%)                   1.00%
CER %, year-on-year 5.00%                   11.00%
Atacand | US                      
Product sales                      
Product Sales $ 4                   $ 6
Actual %, year-on-year 33.00%                   (40.00%)
Atacand | Europe                      
Product sales                      
Product Sales $ 11                   $ 15
Actual %, year-on-year (42.00%)                   (63.00%)
CER %, year-on-year (42.00%)                   (63.00%)
Atacand | World                      
Product sales                      
Product Sales $ 4                   $ 106
Actual %, year-on-year (20.00%)                   (21.00%)
CER %, year-on-year (20.00%)                   (16.00%)
CVRM, Others                      
Product sales                      
Product Sales $ 68 75 75 73 73 85 80 80 90 89 $ 10
Actual %, year-on-year (7.00%)                   (23.00%)
CER %, year-on-year (4.00%)                   (23.00%)
CVRM, Others | Emerging Markets                      
Product sales                      
Product Sales $ 43                   $ 95
Actual %, year-on-year (12.00%)                   (13.00%)
CER %, year-on-year (8.00%)                   (6.00%)
CVRM, Others | US                      
Product sales                      
Product Sales $ 3                   $ 4
CVRM, Others | Europe                      
Product sales                      
Product Sales $ 15                   $ 34
Actual %, year-on-year (17.00%)                   (13.00%)
CER %, year-on-year (17.00%)                   (13.00%)
CVRM, Others | World                      
Product sales                      
Product Sales $ 7                   $ 143
Actual %, year-on-year (13.00%)                   (10.00%)
CER %, year-on-year (13.00%)                   (6.00%)
BioPharmaceuticals, Respiratory                      
Product sales                      
Product Sales $ 1,252 1,283 1,362 1,142 1,226 1,181 1,334 1,092 1,099 1,181 $ 262
Actual %, year-on-year 2.00%                   (14.00%)
CER %, year-on-year 7.00%                   (11.00%)
BioPharmaceuticals, Respiratory | Emerging Markets                      
Product sales                      
Product Sales $ 438                   $ 956
Actual %, year-on-year 26.00%                   22.00%
CER %, year-on-year 36.00%                   30.00%
BioPharmaceuticals, Respiratory | US                      
Product sales                      
Product Sales $ 410                   $ 756
Actual %, year-on-year 1.00%                   12.00%
BioPharmaceuticals, Respiratory | Europe                      
Product sales                      
Product Sales $ 276                   $ 561
Actual %, year-on-year (13.00%)                   (13.00%)
CER %, year-on-year (7.00%)                   (7.00%)
BioPharmaceuticals, Respiratory | World                      
Product sales                      
Product Sales $ 128                   $ 2,535
Actual %, year-on-year (18.00%)                   5.00%
CER %, year-on-year (15.00%)                   10.00%
Symbicort                      
Product sales                      
Product Sales $ 585 585 636 619 672 634 752 668 706 677 $ 171
Actual %, year-on-year (13.00%)                   (20.00%)
CER %, year-on-year (9.00%)                   (17.00%)
Symbicort | Emerging Markets                      
Product sales                      
Product Sales $ 130                   $ 263
Actual %, year-on-year 15.00%                   9.00%
CER %, year-on-year 25.00%                   18.00%
Symbicort | US                      
Product sales                      
Product Sales $ 206                   $ 382
Actual %, year-on-year (20.00%)                   (13.00%)
Symbicort | Europe                      
Product sales                      
Product Sales $ 172                   $ 354
Actual %, year-on-year (14.00%)                   (14.00%)
CER %, year-on-year (7.00%)                   (7.00%)
Symbicort | World                      
Product sales                      
Product Sales $ 77                   $ 1,170
Actual %, year-on-year (26.00%)                   (10.00%)
CER %, year-on-year (23.00%)                   (6.00%)
Pulmicort                      
Product sales                      
Product Sales $ 333 383 389 264 287 346 371 242 226 337 $ 40
Actual %, year-on-year 16.00%                   (5.00%)
CER %, year-on-year 23.00%                   (2.00%)
Pulmicort | Emerging Markets                      
Product sales                      
Product Sales $ 262                   $ 576
Actual %, year-on-year 24.00%                   20.00%
CER %, year-on-year 32.00%                   27.00%
Pulmicort | US                      
Product sales                      
Product Sales $ 32                   $ 56
Actual %, year-on-year 7.00%                   (5.00%)
Pulmicort | Europe                      
Product sales                      
Product Sales $ 19                   $ 44
Actual %, year-on-year (17.00%)                   (12.00%)
CER %, year-on-year (9.00%)                   (6.00%)
Pulmicort | World                      
Product sales                      
Product Sales $ 20                   $ 716
Actual %, year-on-year (9.00%)                   13.00%
CER %, year-on-year (5.00%)                   19.00%
Fasenra                      
Product sales                      
Product Sales $ 167 129 125 86 65 21         $ 42
Fasenra | Emerging Markets                      
Product sales                      
Product Sales 1                   1
Fasenra | US                      
Product sales                      
Product Sales 115                   208
Fasenra | Europe                      
Product sales                      
Product Sales 27                   45
Fasenra | World                      
Product sales                      
Product Sales 24                   296
Daliresp/Daxas                      
Product sales                      
Product Sales $ 56 48 54 52 45 38 53 53 48 44 1
Actual %, year-on-year 24.00%                    
CER %, year-on-year 24.00%                    
Daliresp/Daxas | Emerging Markets                      
Product sales                      
Product Sales $ 1                   2
Daliresp/Daxas | US                      
Product sales                      
Product Sales $ 48                   $ 89
Actual %, year-on-year 26.00%                   33.00%
Daliresp/Daxas | Europe                      
Product sales                      
Product Sales $ 6                   $ 12
Actual %, year-on-year (14.00%)                   (14.00%)
CER %, year-on-year                     (7.00%)
Daliresp/Daxas | World                      
Product sales                      
Product Sales $ 1                   $ 104
Actual %, year-on-year                     25.00%
CER %, year-on-year                     27.00%
Tudorza/Eklira                      
Product sales                      
Product Sales $ 13 20 19 18 39 34 42 37 34 37 $ 3
Actual %, year-on-year (71.00%)                   (50.00%)
CER %, year-on-year (69.00%)                   (50.00%)
Tudorza/Eklira | Emerging Markets                      
Product sales                      
Product Sales $ (2)                   $ (1)
Tudorza/Eklira | US                      
Product sales                      
Product Sales (2)                    
Tudorza/Eklira | Europe                      
Product sales                      
Product Sales $ 15                   $ 31
Actual %, year-on-year (17.00%)                   (18.00%)
CER %, year-on-year (11.00%)                   (13.00%)
Tudorza/Eklira | World                      
Product sales                      
Product Sales $ 2                   $ 33
Actual %, year-on-year (50.00%)                   (55.00%)
CER %, year-on-year (50.00%)                   (52.00%)
Duaklir                      
Product sales                      
Product Sales $ 17 20 22 23 22 28 23 21 16 19 $ 1
Actual %, year-on-year (23.00%)                   (50.00%)
CER %, year-on-year (14.00%)                   (50.00%)
Duaklir | Emerging Markets                      
Product sales                      
Product Sales $ (1)                    
Duaklir | Europe                      
Product sales                      
Product Sales $ 17                   $ 36
Actual %, year-on-year (15.00%)                   (23.00%)
CER %, year-on-year (15.00%)                   (19.00%)
Duaklir | World                      
Product sales                      
Product Sales $ 1                   $ 37
Actual %, year-on-year                     (26.00%)
CER %, year-on-year                     (20.00%)
Bevespi                      
Product sales                      
Product Sales $ 10 10 10 10 8 5 8 4 3 1  
Actual %, year-on-year 25.00%                    
CER %, year-on-year 25.00%                    
Bevespi | US                      
Product sales                      
Product Sales $ 10                   $ 20
Actual %, year-on-year 25.00%                   54.00%
Bevespi | World                      
Product sales                      
Product Sales                     $ 20
Actual %, year-on-year                     54.00%
CER %, year-on-year                     54.00%
Respiratory, Others                      
Product sales                      
Product Sales $ 71 88 107 70 88 75 85 67 66 66 $ 4
Actual %, year-on-year (13.00%)                   (85.00%)
CER %, year-on-year (7.00%)                   (85.00%)
Respiratory, Others | Emerging Markets                      
Product sales                      
Product Sales $ 47                   $ 115
Actual %, year-on-year 96.00%                   89.00%
Respiratory, Others | US                      
Product sales                      
Product Sales $ 1                   $ 1
Respiratory, Others | Europe                      
Product sales                      
Product Sales $ 20                   $ 39
Actual %, year-on-year (55.00%)                   (48.00%)
CER %, year-on-year (55.00%)                   (47.00%)
Respiratory, Others | World                      
Product sales                      
Product Sales $ 3                   $ 159
Actual %, year-on-year (79.00%)                   (2.00%)
CER %, year-on-year (79.00%)                   4.00%
Other medicines                      
Product sales                      
Product Sales $ 641 576 892 832 747 929 1,094 991 1,073 998 $ 265
Actual %, year-on-year (14.00%)                   (14.00%)
CER %, year-on-year (10.00%)                   (10.00%)
Other medicines | Emerging Markets                      
Product sales                      
Product Sales $ 250                   $ 499
Actual %, year-on-year (14.00%)                   (11.00%)
CER %, year-on-year (8.00%)                   (7.00%)
Other medicines | US                      
Product sales                      
Product Sales $ 89                   $ 201
Actual %, year-on-year (37.00%)                   (54.00%)
Other medicines | Europe                      
Product sales                      
Product Sales $ 152                   $ 252
Actual %, year-on-year (1.00%)                   (33.00%)
CER %, year-on-year 3.00%                   (28.00%)
Other medicines | World                      
Product sales                      
Product Sales $ 150                   $ 1,217
Actual %, year-on-year (6.00%)                   (27.00%)
CER %, year-on-year (3.00%)                   (24.00%)
Nexium                      
Product sales                      
Product Sales $ 393 363 390 422 442 448 427 469 595 461 $ 236
Actual %, year-on-year (11.00%)                   (1.00%)
CER %, year-on-year (7.00%)                   2.00%
Nexium | Emerging Markets                      
Product sales                      
Product Sales $ 179                   $ 369
Actual %, year-on-year 11.00%                   8.00%
CER %, year-on-year 19.00%                   15.00%
Nexium | US                      
Product sales                      
Product Sales $ 53                   $ 119
Actual %, year-on-year (39.00%)                   (36.00%)
Nexium | Europe                      
Product sales                      
Product Sales $ 16                   $ 32
Actual %, year-on-year (74.00%)                   (74.00%)
CER %, year-on-year (74.00%)                   (74.00%)
Nexium | World                      
Product sales                      
Product Sales $ 145                   $ 756
Actual %, year-on-year 9.00%                   (15.00%)
CER %, year-on-year 12.00%                   (11.00%)
Losec/Prilosec                      
Product sales                      
Product Sales $ 68 76 60 67 76 69 69 66 68 68 $ 13
Actual %, year-on-year (11.00%)                   (24.00%)
CER %, year-on-year (4.00%)                   (24.00%)
Losec/Prilosec | Emerging Markets                      
Product sales                      
Product Sales $ 45                   $ 96
Actual %, year-on-year 7.00%                   9.00%
CER %, year-on-year 17.00%                   17.00%
Losec/Prilosec | US                      
Product sales                      
Product Sales $ 3                   $ 4
Losec/Prilosec | Europe                      
Product sales                      
Product Sales $ 13                   $ 31
Actual %, year-on-year (35.00%)                   (14.00%)
CER %, year-on-year (30.00%)                   (8.00%)
Losec/Prilosec | World                      
Product sales                      
Product Sales $ 7                   $ 144
Actual %, year-on-year (36.00%)                   (1.00%)
CER %, year-on-year (36.00%)                   6.00%
Synagis                      
Product sales                      
Product Sales $ 96 53 251 164 26 224 234 153 70 230  
Synagis | US                      
Product sales                      
Product Sales 10                   $ 35
Actual %, year-on-year                     (72.00%)
Synagis | Europe                      
Product sales                      
Product Sales 86                   $ 114
Actual %, year-on-year                     (9.00%)
CER %, year-on-year                     (9.00%)
Synagis | World                      
Product sales                      
Product Sales                     $ 149
Actual %, year-on-year                     (40.00%)
CER %, year-on-year                     (40.00%)
Seroquel XR/IR                      
Product sales                      
Product Sales $ 32 37 56 77 131 97 156 113 135 104 $ 11
Actual %, year-on-year (76.00%)                   (39.00%)
CER %, year-on-year (74.00%)                   (39.00%)
Seroquel XR/IR | Emerging Markets                      
Product sales                      
Product Sales $ 10                   $ 24
Actual %, year-on-year (81.00%)                   (74.00%)
CER %, year-on-year (81.00%)                   (72.00%)
Seroquel XR/IR | US                      
Product sales                      
Product Sales $ (7)                   $ (13)
Seroquel XR/IR | Europe                      
Product sales                      
Product Sales $ 24                   $ 47
Actual %, year-on-year (14.00%)                   (16.00%)
CER %, year-on-year (7.00%)                   (13.00%)
Seroquel XR/IR | World                      
Product sales                      
Product Sales $ 5                   $ 69
Actual %, year-on-year (50.00%)                   (70.00%)
CER %, year-on-year (50.00%)                   (68.00%)
Movantik/Moventig                      
Product sales                      
Product Sales $ 22 25 25 32 24 28 30 30 32 30  
Actual %, year-on-year (8.00%)                    
CER %, year-on-year (8.00%)                    
Movantik/Moventig | US                      
Product sales                      
Product Sales $ 22                   $ 45
Actual %, year-on-year (4.00%)                   (12.00%)
Movantik/Moventig | Europe                      
Product sales                      
Product Sales                     $ 2
Movantik/Moventig | World                      
Product sales                      
Product Sales                     $ 47
Actual %, year-on-year                     (10.00%)
CER %, year-on-year                     (10.00%)
FluMist/Fluenz                      
Product sales                      
Product Sales     75 35     58 20      
Other, Others                      
Product sales                      
Product Sales $ 30 $ 22 $ 35 $ 35 $ 48 $ 63 $ 120 $ 140 $ 173 $ 105 $ 5
Actual %, year-on-year (36.00%)                   (86.00%)
CER %, year-on-year (26.00%)                   (69.00%)
Other, Others | Emerging Markets                      
Product sales                      
Product Sales $ 16                   $ 10
Actual %, year-on-year (53.00%)                   (70.00%)
CER %, year-on-year (47.00%)                    
Other, Others | US                      
Product sales                      
Product Sales $ 8                   $ 11
Actual %, year-on-year                     57.00%
Other, Others | Europe                      
Product sales                      
Product Sales $ 13                   $ 26
Actual %, year-on-year 30.00%                   (26.00%)
CER %, year-on-year 60.00%                   14.00%
Other, Others | World                      
Product sales                      
Product Sales $ (7)                   $ 52
Actual %, year-on-year                     (53.00%)
CER %, year-on-year                     (49.00%)